Vanguard Group Inc Verrica Pharmaceuticals Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,286,600 shares of VRCA stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,286,600

Previous 1,269,466 1.35%

Holding current value

$10.2 Million

Previous $9.25 Million 10.53%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.95 - $7.95 $136,215 - $136,215	17,134 Added 1.35%	1,286,600 $10.2 Million
Q2 2024 Aug 13, 2024	BUY	$5.89 - $9.56 $4,452 - $7,227	756 Added 0.06%	1,269,466 $9.25 Million
Q1 2024 May 10, 2024	BUY	$4.74 - $6.81 $36,066 - $51,817	7,609 Added 0.6%	1,268,710 $7.51 Million
Q4 2023 Feb 14, 2024	BUY	$2.93 - $7.32 $100,331 - $250,658	34,243 Added 2.79%	1,261,101 $9.23 Million
Q3 2023 Nov 14, 2023	BUY	$3.75 - $7.46 $9,063 - $18,030	2,417 Added 0.2%	1,226,858 $4.76 Million
Q2 2023 Aug 14, 2023	BUY	$5.32 - $6.79 $567,452 - $724,248	106,664 Added 9.54%	1,224,441 $7.07 Million
Q1 2023 May 15, 2023	BUY	$2.88 - $8.51 $273,568 - $808,356	94,989 Added 9.29%	1,117,777 $7.27 Million
Q4 2022 Feb 10, 2023	BUY	$2.09 - $3.39 $21,301 - $34,550	10,192 Added 1.01%	1,022,788 $2.81 Million
Q2 2022 Aug 12, 2022	BUY	$1.81 - $8.93 $579,990 - $2.86 Million	320,437 Added 46.3%	1,012,596 $1.95 Million
Q1 2022 May 13, 2022	SELL	$7.59 - $9.49 $273 - $341	-36 Reduced 0.01%	692,159 $5.61 Million
Q4 2021 Feb 14, 2022	BUY	$9.1 - $13.36 $172 - $253	19 Added 0.0%	692,195 $6.34 Million
Q3 2021 Nov 12, 2021	BUY	$9.55 - $13.96 $41,685 - $60,935	4,365 Added 0.63%	692,176 $8.65 Million
Q2 2021 Aug 13, 2021	BUY	$9.77 - $15.33 $6.72 Million - $10.5 Million	687,811 New	687,811 $7.77 Million

Others Institutions Holding VRCA

# of Institutions

Shares Held

14.2M

Call Options Held

9.9K

Put Options Held

6.5K

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Verrica Pharmaceuticals Inc. Transaction History